Titan Pharmaceuticals, Inc. Deferred Revenue Recognized
Titan Pharmaceuticals, Inc. reported Deferred Revenue Recognized of $313.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-14.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-03-31
- 2019-08-31: Contract with Customer, Liability, Revenue Recognized 1 month 2.00M EUR.
- 2018-08-31: Contract with Customer, Liability, Revenue Recognized 1 month 2.00M EUR.
- 2018-03-21: Contract with Customer, Liability, Revenue Recognized 2.00M EUR.
EUR
| Period end | Contract with Customer, Liability, Revenue Recognized | Contract with Customer, Liability, Revenue Recognized 1 month |
|---|---|---|
| 2019-08-31 | 2.00M EUR 10-Q · filed 2020-05-15 | |
| 2018-08-31 | 2.00M EUR 10-Q · filed 2020-11-16 | |
| 2018-03-21 | 2.00M EUR 10-K · filed 2021-03-31 |
USD
| Period end | Contract with Customer, Liability, Revenue Recognized | Contract with Customer, Liability, Revenue Recognized 1 month | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month |
|---|---|---|---|---|---|---|
| 2019-09-30 | $313.00K 10-Q · filed 2019-11-14 | |||||
| 2019-08-31 | $2.30M 10-Q · filed 2020-05-15 | |||||
| 2019-06-30 | $313.00K 10-Q · filed 2019-08-14 | |||||
| 2019-03-31 | $300.00K 10-Q · filed 2020-11-16 | $313.00K 10-Q · filed 2019-05-15 | ||||
| 2018-08-31 | $2.30M 10-Q · filed 2020-11-16 | |||||
| 2018-03-21 | $2.30M 10-K · filed 2021-03-31 |